Evolution of the Average Target: Exor N.V.

Evolution of the Average Target - Exor N.V.

Evolution of the Target Price: Exor N.V.

Evolution of the Target Price - Exor N.V.

Changes in Analyst Recommendations: Exor N.V.

3289d0c3e9.6d4BrNW2V47KcAKfy3ycR9kMeb0q7xtvLkbuO5JmLnc.g5ZFz7bgA-KCQluooE-xCLo-E9cZlX8kSn-BffMTRiGBskXP5do4xbAbVw~ad74cf7309b81f1c675ef912681ba958
09-03 AlphaValue/Baader Europe Updates EPS Forecasts for Exor on Expected Dividend Income MT
09-02 Exor: EPS upgrade (2025: +45.4%, 2026: +54.0%) Alphavalue
02-16 AlphaValue/Baader Europe Adjusts Exor Earnings Estimates After Stellantis' Preliminary H2 2025 Results MT
02-13 Exor: EPS cut (2025: -34.6%, 2026: -29.4%) Alphavalue
25-09-26 Exor: Exor H1 2025: Strategy still in waiting Alphavalue
25-09-17 The day the Fed resumed its rate cuts Zonebourse
25-07-02 Exor: Target upgrade by 17.8% Alphavalue
25-03-27 Exor: Exor's strategic moves: Market lagging behind Alphavalue
25-03-26 BNP Paribas Exane Upgrades Exor to Outperform MT
24-12-03 Exor: Adjustments following Exor's reclassification as an Investment Entity Alphavalue
24-12-02 Exor: Stellantis' woes likely to spill over to Exor Alphavalue
24-10-02 KBC Securities Starts Exor at Buy MT
24-09-25 Exor: NAV progresses further Alphavalue
24-07-23 AlphaValue/Baader Europe Upgrades Exor to Buy, Raises PT MT
24-07-23 Exor: Opinion change, from Add to Buy Alphavalue
24-04-11 Exor: Stellantis and Ferrari continue to push Exor forward Alphavalue
24-03-05 Exor: Exor is adept for recovery bets Alphavalue
24-02-19 Exor: NAV cut by -8.8% Alphavalue
23-12-01 Exor : Exor reiterates its faith in Philips Alphavalue
23-09-14 Exor : Exor pushes the throttle Alphavalue
23-08-16 Exor : Exor delivers on its diversification strategy Alphavalue
23-07-03 Exor : EPS upgrade (2022: -20.5%, 2023: +13.5%) Alphavalue
23-05-30 Analysts recommendations: Alliant Energy, Coinbase, Constellation Brands, Medtronic... Zonebourse
23-04-17 Exor : 2022: Another milestone year in Exor's Equity Story Alphavalue
23-01-19 Exor : All eyes on Juventus with Exor and Stellantis potentially impacted Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+43.75%
+36.63%
+3.96%
+13.76%
+24.1%
+15.79%
+20.42%
+25.09%
+14.55%
+28.72%
Average +22.68%
Weighted average by Cap. +22.68%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
71.85EUR
Average target price
103.29EUR
Spread / Average Target
+43.75%
High Price Target
120.00EUR
Spread / Highest target
+67.01%
Low Price Target
89.00EUR
Spread / Lowest Target
+23.87%

Analyst Consensus Detail

Analyst consensus - Exor N.V.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Exor N.V.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Exor N.V.